Login / Signup

Rapid rituximab infusion is safe and well tolerated in malignant and benign disease.

Sorana G UrsuDerek L RinchuseJohn Lister
Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)
The use of the rapid rituximab administration is safe and well tolerated in both benign and malignant disease.
Keyphrases
  • diffuse large b cell lymphoma
  • low dose
  • hodgkin lymphoma
  • loop mediated isothermal amplification
  • chronic lymphocytic leukemia